Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 1, 2005

View Archived Issues

Combined statin and L-arginine treatment opens new possibilities for clinical research

XOS supplementation reported to improve the gastrointestinal microflora of obese patients

Sho-saiko-to selectively inhibits CD8+ cells

STELLAR 3 trial of Xyotax reaches required number of events

Orphan drug designation for Tocosol Paclitaxel for bladder cancer indication

Agreements to develop AP-23573 drug delivery stents

Tarvacin cleared to enter new phase I study

NIDA grant supports drug addiction therapy development at InfleXion

Orphan drug status for PTC-124 for Duchenne muscular dystrophy

Quadramet and docetaxel to be evaluated for cancer spread to bone

GSK and Transport sign agreement for iontophoretic delivery of aciclovir

Thiazolidinediones show promise in the treatment of diabetic vascular complications

Fast track status for Viprinex for ischemic stroke

Analgesic effects reported for AM-404 in a model of neuropathic pain

Enrollment completed in study of Durin-leuprolide implant for Alzheimer's

Provensis seeks to lift Varisolve clinical hold

Neuroprotective effects of ethyl pyruvate in a preclinical model of Parkinson's disease

Chiesi and Novartis sign agreement for Formoterol Modulite

Tanabe Seiyaku signs addendum to Remicade license agreement in Japan

Rigel claims agents for hepatitis C infection

Kowa scientists describe new compounds for diabetes and related complications

New MCHR antagonists for obesity and other uses reported by Banyu

Two series of cannabinoid receptor modulators disclosed by Japan Tobacco

Pharmacia identifies new protein kinase inhibitors

New DPP-IV inhibitors discovered at Syrrx

5HT-7 receptor modulators and their use in IBS claimed by Ajinomoto

Amgen launches Kepivance

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....